Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
January 28, 2020 Off

Global Stem Cell Banking Market Analysis, Trends, and Forecasts 2019-2025 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Stem Cell Banking – Market Analysis, Trends, and Forecasts” report has been added to ResearchAndMarkets.com’s offering. The global…

January 28, 2020 Off

ClinOne Announces ‘Coordinator of the Month’ Award Highlighting Work of Outstanding Research Professionals

By BusinessWire

DENVER–(BUSINESS WIRE)–#clinicalresearch–ClinOne is proud to announce our new Coordinator of the Month program to honor and highlight outstanding performance by…

January 28, 2020 Off

Fractyl Announces First-Ever Commercial Availability of Revita for Type 2 Diabetes in Partnership with Leading UK Private Clinic

By BusinessWire

LEXINGTON, Mass.–(BUSINESS WIRE)–#RevitaDMR–Fractyl Laboratories Inc. (Fractyl) today announced its first commercial partnership with HCA Healthcare UK (United Kingdom), making its…

January 28, 2020 Off

Sengenics, a Leading Precision Medicine Focused Company, to Present at the Annual BIO CEO and Investor Conference

By BusinessWire

SINGAPORE–(BUSINESS WIRE)–Sengenics, a leading precision medicine focused company, today announced that Dr Arif Anwar, CEO of Sengenics, will present a…

January 28, 2020 Off

Sengenics, a Leading Precision Medicine Focused Company, to Present at the Annual BIO CEO and Investor Conference

By BusinessWire

SINGAPORE–(BUSINESS WIRE)–Sengenics, a leading precision medicine focused company, today announced that Dr Arif Anwar, CEO of Sengenics, will present a…

January 28, 2020 Off

Syros Announces First Patient Dosed in Phase 1 Clinical Trial of SY-5609, Its Highly Selective and Potent Oral CDK7 Inhibitor, in Patients with Select Solid Tumors

By BusinessWire

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Syros Pharmaceuticals (NASDAQ: SYRS), a leader in the development of medicines that control the expression of genes, today…

January 28, 2020 Off

Syros Announces First Patient Dosed in Phase 1 Clinical Trial of SY-5609, Its Highly Selective and Potent Oral CDK7 Inhibitor, in Patients with Select Solid Tumors

By BusinessWire

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Syros Pharmaceuticals (NASDAQ: SYRS), a leader in the development of medicines that control the expression of genes, today…

January 28, 2020 Off

OncoSec Urges Shareholders Not to Fall for Alpha’s Disingenuous “Proposal” and Scheme to Prevent Fair Vote at Special Meeting

By BusinessWire

Alpha’s Latest Release Merely Resurfaces Earlier “Proposal” in its Entirety, Just with a New Expiration Date – This is Meaningless…

January 28, 2020 Off

Acerus Announces Acceptance of NATESTO® Spermatogenesis Study Results for Presentation at ENDO 2020

By BusinessWire

TORONTO–(BUSINESS WIRE)–Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX:ASP, OTCQB:ASPCF) today announced the acceptance of a scientific abstract reporting the…

January 28, 2020 Off

Acerus Announces Acceptance of NATESTO® Spermatogenesis Study Results for Presentation at ENDO 2020

By BusinessWire

TORONTO–(BUSINESS WIRE)–Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX:ASP, OTCQB:ASPCF) today announced the acceptance of a scientific abstract reporting the…

Posts pagination

Previous 1 … 5,171 5,172 5,173 … 6,215 Next

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Rare Diseases Treatment Market Analysis and Forecast 2025-2032: A $45.8 Billion Opportunity – Complex Challenges and Unprecedented Opportunities are Emerging – ResearchAndMarkets.com

December 19, 2025 Off
Cosentyx meets the primary endpoints

Cosentyx meets the primary endpoints

June 15, 2015 Off
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off
Strensiq in HPP patiens therapy get approval from European Commission

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine